跳至主要内容
临床试验/NCT00144729
NCT00144729已完成1 期

Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor

Fred Hutchinson Cancer Center2 个研究点 分布在 1 个国家目标入组 85 人开始时间: 1993年5月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
85
试验地点
2
主要终点
Sustained engraftment; survival

研究概览

简要总结

A single arm dose optimization study in which all patients are given a fixed dose of Cytoxan (4 x 50 mg/kg) plus ATG (3 x 30 mg/kg) and the TBI dose starting at 3 x 200 cGy is escalated or de-escalated dependent upon engraftment and toxicity.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 55 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Life-threatening marrow failure of nonmalignant etiology;
  • failure to respond to the best available immunosuppressive treatment;
  • lack of a HLA-identical family member

排除标准

  • Severe disease other than aplastic anemia that would severly limit the probability of survival during the graft procedure;
  • HIV seropositive patients;
  • clonal abnormalities or myelodysplastic syndrome;

结局指标

主要结局

Sustained engraftment; survival

次要结局

  • Acute and chronic GVHD

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验